Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
PEPITEM-derived tripeptides reduced splenomegaly, the enlargement of the spleen that indicates systemic inflammation, and limited the expansion of CD4+, CD8+, TH1, and TH17 cell populations
Pheomelanin, on the other hand, creates lighter yellow and red tones
Requests are usually considered after the research is finished and the main results have been published
Bluum Peptides supplies 98%+ pure lyophilized Cagrilintide peptide, verified by accredited third-party labs to support research consistency and reproducibility
Frias DOM 2020
Research Applications Obesity and body weight regulation research Type 2 diabetes and glycemic control studies Appetite and satiety pathway research Amylin and GLP-1 receptor signaling studies Gastric emptying and postprandial glucose research Combination peptide pharmacology studies Energy intake and food reward research Cardiometabolic risk factor studies Hypothalamic appetite circuit research Comparative metabolic peptide studies Safety Profile The safety profile of the cagrilintide + semaglutide blend draws on the substantial individual safety datasets for each peptide as well as growing combination data from Phase 1b and Phase 2 clinical research
